FDA NDC Directory · JSON-LD · Markdown

dabigatran etexilate

NDC 60505-4348 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA208070
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (150 mg/1)
Marketing started20240213
Package count1

External sources

Source: openFDA. Public-domain (CC0).